Sunita Nair
Senior Director, Systematic Literature Reviews and Meta-analysis
Sunita Nair is a Practice Head at Clarivate, leading our Systematic Literature Reviews and Meta- analysis Centre of Excellence. Sunita is a business leader with 25 years experience and provides leadership to our highly skilled team of systematic reviewers and meta-analysis experts. She has supported several US FDA and HTA submissions. She has formerly worked in tertiary hospitals and multinational pharmaceutical companies (Sanofi, Novartis) in India. She has vast experience in establishing businesses, and managing teams providing services in HEOR, medical writing and clinical development. Her core areas of interest include cardiovascular research, HEOR, knowledge management, market access, market research, medical communications, molecular diagnostics, and scientific writing.
Sunita is a regular speaker at scientific conferences, on the review panel of several journals, and a National Executive Committee member of the ISPOR India chapter.
Sunita has a PhD in Applied Biology (Molecular Biology) and a master’s degree in Microbiology from the University of Mumbai, and a Post-Graduate Diploma in Global Health Policy from the London School of Hygiene and Tropical Medicine. She is also trained in Knowledge Management, carried out at the Indian Institute of Management.
Latest news
Clarivate’s IPfolio and Renewal Services Selected by IGT
Managing global intellectual property more efficiently with trusted data, expert support and integrated services London, U.K. May 21, 2026: Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today…
Clarivate Selected By Czech National Library of Technology to Develop Unified National Library Platform
New cloud-based, shared platform based on Alma and Primo to help National Library of Technology advance library services and information accessibility London, U.K. May 19, 2026: Clarivate Plc (NYSE:CLVT), a…
Clarivate Identifies Five Medtech Trends Set to Redefine Growth Opportunities in 2026
New Medtech Trends to Watch report highlights market shifts, care delivery changes and competitive dynamics poised to reshape medtech strategy London, U.K. May 13, 2026. Clarivate Plc (NYSE:CLVT), a leading…
